Inspired by the neuroprotective role of PPARγ agonists in several neurodegenerative diseases [455], investigators have tested the brain penetrant full PPARγ agonist leriglitazone in Abcd1:Abcd2 double KO mice [456]. This evidence concerns the gene PPARG and neurodegenerative disease.